Ex Parte Lal et al - Page 12


               Appeal No. 2006-1035                                                                          Page 12                   
               Application No. 09/925,140                                                                                              

                       structural features common to the members of the genus, which features                                          
                       constitute a substantial portion of the genus.                                                                  
               Id.  The court has since clarified that the description of representative species does not                              
               necessarily have to include their complete structure (nucleotide sequence).  See Enzo                                   
               Biochem, Inc. v. Gen-Probe Inc., 323 F.3d 956, 964, 63 USPQ2d 1609, 1613 (Fed. Cir.                                     
               2002).                                                                                                                  
                       The holding of Eli Lilly supports our conclusion that the instant specification does                            
               not adequately describe the claimed genus of DNAs – those that encode naturally                                         
               occurring sequences at least 90% identical to SEQ ID NO:1.  The Eli Lilly court held that                               
               a fully described genus is one for which a person skilled in the art can “visualize or                                  
               recognize the identity of the members of the genus.”  Here, the specification provides no                               
               description of DNAs that encode naturally occurring variants of SEQ ID NO:1 that would                                  
               allow a person skilled in the art to determine whether a given DNA encoding an amino                                    
               acid sequence at least 90% identical to SEQ ID NO:1 is within the scope of the instant                                  
               claims.                                                                                                                 
                       The recitation of “naturally occurring” sequences does not imply any structural                                 
               features that would distinguish the claimed DNAs from non-naturally occurring DNAs.                                     
               Since the specification does not describe the claimed DNAs adequately for those skilled                                 
               in the art to distinguish the claimed DNAs from other DNAs, the specification does not                                  
               adequately describe the claimed DNAs under the standard of Eli Lilly.7                                                  

                                                                                                                                       
               7 Our conclusion is also consistent with the Eli Lilly court’s treatment of claims directed to cDNA encoding            
               human insulin.  The court noted that a description that merely renders obvious a claimed invention does                 
               not describe that invention adequately to satisfy 35 U.S.C. § 112, first paragraph, and that a claim to a               
               specific DNA is not made obvious by knowledge of the encoded protein sequence and a method of                           
               obtaining the DNA.  119 F.3d at 1567, 43 USPQ2d at 1405 (citing Lockwood v. American Airlines, Inc.,                    
               107 F.3d 1565, 41 USPQ2d 1961 (Fed. Cir. 1997), and In re Deuel, 51 F.3d 1552, 34 USPQ2d 1210                           





Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next 

Last modified: November 3, 2007